Source: https://www.audioeducator.com/pharma-biotech/fda-inspections-21-cfr-11-03-15-2016.html
Timestamp: 2019-01-22 06:32:45
Document Index: 692267661

Matched Legal Cases: ['art 11', 'art 11', 'art 11', 'art 11', 'art 11', 'art 11']

﻿ FDA’s Add-On Inspections For 21 CFR 11 By Angela Bazigos
FDA’s Add-On Inspections for 21 CFR 11
Conference Material (Password Required) (1002.0 KB)
21 CFR 11 FDA Add-On Inspections
In December 2010 FDA started the Part 11 inspection initiative. While originally the initiative was supposed to last 3-6 months, it has now turned into an ongoing program with Part 11 related issues being part of most future inspections. At the beginning of the initiative FDA made it very clear that Part 11 is in effect and is enforced according to the original Part 11 and the Guidance from 2003. In the meantime FDA officials reported about key findings. For example, George Smith who heads up FDA's Part 11 working group gave an update with examples of violations. This presentation with Angela Bazigos will cover the scope, status and results of the surveillance inspections and what they may mean for the future of 21 CFR Part 11. This will enable you to determine whether your company is subject to the most common violations so you can take action to have a better inspection outcome.
Very little is known about this, yet the FDA has already issued citations on the subject. This Webinar will present the latest on FDA thinking (with slides directly from the FDA's Office of Compliance), discuss how these inspections will impact both your company and the industry, and provide guidance on how your company can ensure that they have a successful inspection.
Seafood HACCP — What You Need to...
Transcript: $249.00 Instant Access: $249.00 CD: $271.00 Podcast: $99.00
Instant Access + Transcript: $349.00 CD + Transcript: $371.00 CD + Transcript + Instant Access: $471.00